• Skip navigation
  • Skip to navigation
  • Skip to the bottom
Simulate organization breadcrumb open Simulate organization breadcrumb close
German Chronic Kidney Disease (GCKD)
  • FAUTo the central FAU website
  1. Friedrich-Alexander-Universität
  2. Faculty of Medicine
  • Deutsch
  • English
  • Medizin 4
  • Askimed-GCKD
  1. Friedrich-Alexander-Universität
  2. Faculty of Medicine

German Chronic Kidney Disease (GCKD)

Navigation Navigation close
  • Team
    • Steering commitee
    • Coordinating center
    • Regional teams
    • Cooperating institutions
    • University centers
    • Cooperating study sites
    Portal About us
  • Background
    • Background
    • Goals
    Portal Background
  • Partner
    • International cooperations
    • Industrial Partners
    • Biobank consortium
    Portal Partner
  • Publications
    • 2022
    • 2021
    • 2020
    • 2019
    • 2018
    • 2017
    • 2016
    • 2015
    • 2010-2013
    Portal Publications
  1. Home
  2. Partner
  3. International cooperations
  4. BEAt-DKD

BEAt-DKD

In page navigation: Partner
  • International cooperations
    • BEAt-DKD
    • CKD-PC und INet CKD
  • Industrial Partners
  • Biobank consortium

BEAt-DKD

Blood vessels in the kidneys constrict which makes the vessel walls more permeable and stops renal corpuscles from filtering the blood efficiently. Diabetes-related kidney disease often ends fatally despite dialysis or renal transplantation – the mortality rate is even higher than most forms of cancer. Currently there is no form of therapy which can avoid or cure diabetic kidney disease.

A consortium consisting of more than 20 academic institutions based in Europe and the USA, various pharmaceutical and biotechnology businesses and the Juvenile Diabetes Research Foundation have launched the BEAt-DKD (‘Biomarker Enterprise to Attack Diabetic Kidney Disease’) project with the aim of improving the options available to prevent and treat diabetes-induced kidney disease. The consortium plans to identify the mechanisms and signal pathways that are involved in the development of kidney damage in the presence of diabetes. It is hoped that once such mechanisms have been identified, these can be used as a starting point for the creation of new therapeutic approaches. Researchers also aim to pinpoint biomarkers such as proteins or metabolic substances which indicate disease development. These biomarkers should help to predict the course of the disease and treatment success leading to less extensive clinical trials and more accurate therapy.

Read more on the BEAt-DKD study at

  • https://www.beat-dkd.eu/
  • www.imi.europa.eu/content/beat-dkd

 

 

Friedrich-Alexander-Universität
Erlangen-Nürnberg

Schlossplatz 4
91054 Erlangen
  • Imprint
  • Privacy
  • Accessibility
Up